Kursprognose für Moderna Inc (MRNA)MRNAModerna Inc

Alphio's MRNA stock price prediction model matches the current Moderna Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $200.94 (+0.42%). The 1-week path is $200.64 (+0.27%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Moderna Inc is not a good buy right now due to significant recent price volatility and negative sentiment stemming from a data leak. The current price is $200.1, with a recent drop of 25% following the leak, indicating a lack of investor confidence. Additionally, the RSI is at 37.586, suggesting that the stock is oversold, but this could be a trap given the negative catalysts. The forward P/E ratio is 23.0415, which is high considering the company's recent performance and the downgrade from several analysts, including Citi, which has a target of $80. The main risk is the ongoing insider selling, which has increased by 437.15% over the last quarter, indicating a lack of confidence from those closest to the company.

Moderna Inc (MRNA) last closed at $200.1, losing -1.25%. These facts feed the 1-day and 1-week MRNA price prediction above.